Systemic lupus erythematosus following prolonged treatment with hydralazine.
D001772:Blood Cell Count; D005455:Fluorescent Antibody Technique; D006452:Hemoglobinometry; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils
D006830:Hydralazine